data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Ikena Oncology
(NASDAQ:IKNA)
$4.48
-0.22[-4.68%]
At close: Jun 29
$4.48
00
After Hours: 4:08PM EDT
Day High/Low4.34 - 4.7
52 Week High/Low2.83 - 17.6
Open / Close4.64 / 4.48
Float / Outstanding23.4M / 36.2M
Vol / Avg.133.1K / 288.9K
Mkt Cap162M
P/E5.66
50d Avg. Price4.15
Div / Yield-
Payout Ratio-
EPS-0.47
Total Float23.4M

Ikena Oncology (NASDAQ:IKNA), Quotes and News Summary

Ikena Oncology (NASDAQ: IKNA)

Day High/Low4.34 - 4.7
52 Week High/Low2.83 - 17.6
Open / Close4.64 / 4.48
Float / Outstanding23.4M / 36.2M
Vol / Avg.133.1K / 288.9K
Mkt Cap162M
P/E5.66
50d Avg. Price4.15
Div / Yield-
Payout Ratio-
EPS-0.47
Total Float23.4M
Benzinga - 2 days ago
Benzinga - Jun 22, 2022, 8:30AM
Benzinga - Jun 22, 2022, 7:30AM
Benzinga - May 13, 2022, 7:11AM
Benzinga - May 12, 2022, 7:24AM
Benzinga - Apr 27, 2022, 5:20PM
Benzinga - Apr 13, 2022, 7:04AM
Benzinga - Apr 13, 2022, 6:19AM
Benzinga - Apr 7, 2022, 1:22PM
Benzinga - Mar 17, 2022, 10:46AM
Benzinga - Mar 17, 2022, 7:23AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Ikena Oncology Inc is a targeted oncology company developing precision medicines tailored to biomarker-defined patient groups with specific unmet needs. Its lead targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, transcription factor in the Hippo signaling pathway. The Hippo pathway is genetically altered in approximately 10% of human cancers and is widely accepted as a prevalent driver of cancer pathogenesis and a mediator of poor outcomes for patients.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.420-0.470 -0.0500
REV4.570M3.384M-1.186M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Ikena Oncology Questions & Answers

Q
How do I buy Ikena Oncology (IKNA) stock?
A

You can purchase shares of Ikena Oncology (NASDAQ: IKNA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Ikena Oncology's (IKNA) competitors?
Q
What is the target price for Ikena Oncology (IKNA) stock?
A

The latest price target for Ikena Oncology (NASDAQ: IKNA) was reported by Credit Suisse on Friday, May 13, 2022. The analyst firm set a price target for 20.00 expecting IKNA to rise to within 12 months (a possible 346.43% upside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Ikena Oncology (IKNA)?
A

The stock price for Ikena Oncology (NASDAQ: IKNA) is $4.48 last updated June 29, 2022, 8:00 PM UTC.

Q
Does Ikena Oncology (IKNA) pay a dividend?
A

There are no upcoming dividends for Ikena Oncology.

Q
When is Ikena Oncology (NASDAQ:IKNA) reporting earnings?
A

Ikena Oncology’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Ikena Oncology (IKNA) going to split?
A

There is no upcoming split for Ikena Oncology.

Q
What sector and industry does Ikena Oncology (IKNA) operate in?
A

Ikena Oncology is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.